Kenneth Cole and Zynga to Bring First-of-its-Kind Pride Month Partnership to Rollic's Hyper-Casual Game High Heels!
Kenneth Cole and Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced a partnership to debut the Kenneth Cole PRIDE 2021 collection in the hit hyper-casual game High Heels!. This collaboration marks the first time that Kenneth Cole’s iconic street-smart style will be featured in a mobile game. For the first two weeks of June, gamers will be able to play with pride as they outfit their character and strut the virtual runway in product from the Kenneth Cole PRIDE 2021 collection, including the brand’s iconic KAM sneakers, shirts that proudly state “Being Different is What We Have in Common” and other accessories such as sunglasses, watches and mask lanyards.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210527005009/en/
Kenneth Cole and Zynga to Bring First-of-its-Kind Pride Month Partnership to Rollic's Hyper-Casual Game High Heels! (Graphic: Business Wire)
At Kenneth Cole, there has always been a rich history of supporting public health and civil liberties. For almost 40 years, the man and the brand have nurtured and maintained a global culture of equity and inclusion. In 2020, Kenneth Cole founded The Mental Health Coalition, whose mission is to build a like-minded community that will work together to destigmatize all mental health conditions, enabling equitable access to vital resources and support for all. For every PRIDE product purchased on kennethcole.com, a percentage of net sales will be donated to The Mental Health Coalition. MHC is proud to offer resources specific to LGBTQ+ communities, including an LGBTQ+ mental health guide and the ability to connect with its member organizations for support.
“As a brand, we have been supporting equal rights for the LGBTQ+ community for almost 30 years. For our latest initiative, in recognition of Pride, we are proud to partner with Zynga, a company with shared values, to further highlight the importance of inclusion and acceptance,” said Kenneth Cole, Chairman and Chief Creative Officer of Kenneth Cole Productions, Inc. “We are including our PRIDE product in High Heels!, allowing millions of people to experience celebrating Pride, and as a reminder that ‘being different is what we have in common.’”
“At Zynga we believe, unequivocally, that our strength is in our diversity and that we are called to celebrate our differences. We are proud to stand in solidarity with the LGBTQ+ community in celebration of Pride Month,” said Frank Gibeau, Chief Executive Officer of Zynga. “We’re thrilled to be partnering with a revered, boundary-pushing brand like Kenneth Cole to increase representation in our games and empower players to show their pride, spirit and fashion in High Heels!; it’s a perfect fit.”
Developed by Rollic, a subsidiary of Zynga, High Heels! has been downloaded over 60 million times and has been enthusiastically received all around the world. In the game, players maneuver an increasingly challenging catwalk in high heels, which stack higher as they complete levels. The stakes rise as players progress through a series of worldwide fashion shows in global cities including London, Beijing, Paris and New York. Earning access to new customization elements as they advance, players can update their character with new clothing, fashion, hairstyles and shoes.
High Heels! is available to download for free on the App Store as well as Google Play. Kenneth Cole PRIDE product is available on KennethCole.com. The 2021 PRIDE capsule includes:
- KAM sneaker with rainbow stripe
- T-shirt with rainbow graphic “Being Different is What We Have in Common”
- Mask lanyards in rainbow
- Sunglasses
- Watch
Editor’s Note:
Photos of the collection and other key art from High Heels! can be downloaded here:
https://www.dropbox.com/sh/9kkjzkthgtwwh4y/AACIjzTt9saFabc74KqRF6gFa?dl=0
About Zynga Inc.
Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing™, Empires & Puzzles™, Merge Dragons!™, Merge Magic!™, Toon Blast™, Toy Blast™, Words With Friends™ and Zynga Poker™. Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com or follow Zynga on Twitter, Instagram, Facebook or the Zynga blog.
About Kenneth Cole Productions, Inc.
Kenneth Cole is an American designer, social activist, and visionary who believes business and philanthropy are interdependent. His global company, Kenneth Cole Productions, creates modern, functional, and versatile footwear, clothing, and accessories for inspirational urban lifestyles under the labels Kenneth Cole New York, Reaction Kenneth Cole, and Unlisted, as well as footwear under the label Gentle Souls. The company has also granted a wide variety of third party licenses for the production of men’s and women's apparel, fragrances, watches, jewelry, eyewear, and several other accessory categories, including children’s footwear. The company's products are distributed through department stores, better specialty stores, company-owned retail stores and its e-commerce website.
Over 35 years ago, Kenneth Cole leveraged his passion and unique brand platform to make a meaningful impact on people’s wardrobes, as well as communities in need. He did what others didn’t and said what others wouldn’t. Today, The Kenneth Cole Foundation remains committed to helping communities in need by supporting Public Health and Civil Liberties.
About Rollic
Founded in December 2018, Rollic is an Istanbul-based game developer and publisher, focused on free-to-play hyper-casual games for iOS and Android. Games released by Rollic include Blob Runner 3D, Flipper Dunk, Go Knots 3D, High Heels!, Onnect – Pair Matching Puzzle, Pixel Shot 3D, Picker 3D, Repair Master 3D, Tangle Master 3D, Water Shooty and Wheel Smash. Rollic is committed to producing massively appealing global titles while building a thriving developer ecosystem in the gaming industry. Rollic was acquired by Zynga, a global leader in interactive entertainment, in October 2020. For more information, visit www.rollicgames.com or follow Rollic on Facebook, LinkedIn, Instagram, Twitter or the Rollic blog.
Forward Looking Statements
This press release contains forward-looking statements, relating to, among other things, events and featuring in the game High Heels!. Forward-looking statements often include words such as “outlook,” “projected,” “planned,” “intends,” “will,” “anticipate,” “believe,” “target,” “expect,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties, and assumptions is or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s website at www.sec.gov.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005009/en/
Contact information
Sarah Ross (sarah@zynga.com)
Dana Whitney (dwhitney@zynga.com)
Kenny Johnston (kjohnston@zynga.com)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina17.9.2025 15:30:00 EEST | Press release
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced the opening of a state-of-the-art model development center in Kannapolis, North Carolina. This strategic investment expands the company’s operations and enhances its ability to deliver advanced preclinical oncology models, including patient-derived xenografts (PDX), PDX warm models, PDX-derived organoids (PDXO), and patient-derived organoids (PDO), to meet the evolving needs of pharmaceutical and biotechnology companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917864004/en/ Crown Bioscience celebrate the official ribbon-cutting ceremony for the company’s new Kannapolis, North Carolina facility, marking an expansion of US oncology model development and preclinical CRO services. The new facility strengthens Crown Bioscience’s US-based capabil
SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment17.9.2025 15:00:00 EEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid dermatology model that integrates insurance-covered general dermatology and private-pay aesthetic treatments, advancing SBC’s multi-brand strategy in the rapidly expanding aesthetic medicine market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917897380/en/ SBC Medical Accelerates Multi-Brand Strategy with Hybrid Dermatology Model “Hada no Aozora Clinic” Establishment As life expectancy continues to rise and demographic aging accelerates, more people are seeking treatments that help them maintain both well-being and a youthful appearance over a longer lifespan. Within this environment, aesth
Merck to Present New Data Highlighting Durable Effects of MAVENCLAD ® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 202517.9.2025 15:00:00 EEST | Press release
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New four-year data from two large Phase 4 studies highlight the long-term efficacy, favorable disability outcomes and durable impact of MAVENCLAD® (cladribine tablets) in people living with relapsing multiple sclerosis (RMS). These findings are to be presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), being held September 24-26 in Barcelona. “As the only high-efficacy short-course oral treatment, MAVENCLAD has demonstrated sustained benefits across a variety of outcomes—extending beyond relapses and MRI—without requiring continuous immunosuppression,” said Alex Kulla, Senior Vice President & Global Head of the Neurology & Immunology Medical Unit for the Healthcare business of Merck. “With over two decades of clinical experience an
Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board17.9.2025 15:00:00 EEST | Press release
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase 1b/2a study with lead drug candidate RLS-1496 in patients with actinic keratosis. RLS-1496 is a first-in-class disease-modifying selective glutathione peroxidase 4 (GPX4) modulator targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases and conditions associated with the biological aging process. The study is expected to begin in Q4 2025. The first EMA-cleared RLS-1496 clinical trial began in May 2025 for plaque psoriasis, atopic dermatitis, and skin aging (photoaged skin); study results are expected in Q4 2025. Actinic keratosis is a rough, scaly patch caused by sun exposure that appears on sun-exposed areas of the skin, such as
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs17.9.2025 15:00:00 EEST | Press release
Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical Center in New Hampshire demonstrated that use of Masimo technologies to continuously monitor general floor patients can yield significant cost savings.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917266545/en/ Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™ In prior studies, the clinical outcome benefits of continuously monitoring patients using Masimo SET® and Patient SafetyNet™ have been shown to include lower mortality, improved resuscitative outcomes, and fewer rapid response team activations and transfers to higher-acuity care units, achieved through earlier detection and intervention to prevent patient deterioration.2-5 Now, in this new retrospective analysis – involving 3-1/2 years of data and almost
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom